MedPath

Effect of Narikela lavana in Amlapitta (hyperacidity)

Phase 2
Completed
Conditions
Health Condition 1: K928- Other specified diseases of the digestive system
Registration Number
CTRI/2019/02/017741
Lead Sponsor
Dean Faculty of Ayurved Parul University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
33
Inclusion Criteria

Diagnosed cases of non ulcer dyspepsia according to Rome III criteria

Patients of Amlapitta showing symptoms Udarashoola,udaragurutwam, Amlodgara, hrd-kanta daha, hrllasa, klama with chronicity not more than one month.

Exclusion Criteria

evidence of internal bleeding/ulcer like hematemesis, malena etc

under gastric irritant drugs like aspirin, antacids etc

metabolic disorders like diabetes mellitus, hypertension, hyperthyroidism

pregnancy & lactation

Alcoholic & habitual smoker

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptoms of Amlapitta such as Udarashoola, Udara Gurutva, Tikta Amla Udgara, Hrit Kantha Daha, Hrillas, Klama and Utklesha according to Gastro Intestinal Symptom Rating Scale (GSRS)Timepoint: Symptoms of Amlapitta accessed at baseline and at the interval of 7 days till the end of 14 days
Secondary Outcome Measures
NameTimeMethod
Assessment of quality of life according to Quakity of Life In Reflux and Dyspepsia (QoLRAD)Timepoint: Accessed at the interval of each 7 days till the end of 14 days
© Copyright 2025. All Rights Reserved by MedPath